Christopher Melén

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: CANNABIS AND CANNABINOID RESEARCH. 2024;9(3):e839-e846
Δ⁹-THC and CBD in Plasma, Oral Fluid, Exhaled Breath, and Urine from 23 Patients Administered Sativex
Melen CM; Merrien M; Wasik AM; Sander B; Wahlin BE; Panagiotis G; Beck O
Article: CANCERS. 2023;15(5):1585
2-Arachidonoylglycerol Modulates CXCL12-Mediated Chemotaxis in Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia
Merrien M; Wasik AM; Melen CM; Morsy MHA; Sonnevi K; Junlen H-R; Christensson B; Wahlin BE; Sander B
Article: LEUKEMIA AND LYMPHOMA. 2022;63(6):1387-1397
Clinical effects of a single dose of cannabinoids to patients with chronic lymphocytic leukemia
Melen CM; Merrien M; Wasik AM; Panagiotidis G; Beck O; Sonnevi K; Junlen H-R; Christensson B; Sander B; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2021;192(1):75-81
Survival of very elderly patients with diffuse large B-cell lymphoma according to treatment intensity in the immunochemotherapy era: a Swedish Lymphoma Register study
Sonnevi K; Wasterlid T; Melen CM; Harrysson S; Smedby KE; Wahlin BE
Article: FRONTIERS IN IMMUNOLOGY. 2019;10:2085
Systemic and Intra-Nodal Activation of NK Cells After Rituximab Monotherapy for Follicular Lymphoma
Enqvist M; Jacobs B; Junlen HR; Schaffer M; Melen CM; Friberg D; Wahlin BE; Malmberg K-J
Article: EXPERIMENTAL HEMATOLOGY & ONCOLOGY. 2019;8:7
The Karolinska experience of autologous stem-cell transplantation for lymphoma: a population-based study of all 433 patients 1994-2016
Carlsten M; Jadersten M; Hellstrom A; Littmann K; Melen CM; Junlen HR; Sonnevi K; Ljungman P; Bjorkstrand B; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(4):614-622
Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study
Melen CM; Enblad G; Sonnevi K; Junlen HR; Smedby KE; Jerkeman M; Wahlin BE
Article: BRITISH JOURNAL OF HAEMATOLOGY. 2016;175(1):102-114
The tumour microenvironment influences survival and time to transformation in follicular lymphoma in the rituximab era
Blaker YN; Spetalen S; Brodtkorb M; Lingjaerde OC; Beiske K; Ostenstad B; Sander B; Wahlin BE; Melen CM; Myklebust JH; Holte H; Delabie J; Smeland EB

Alla övriga publikationer

Thesis / dissertation: 2024
Exploring cannabinoids for indolent B-cell lymphomas
Melén, Christopher

Anställningar

Anknuten till Forskning, Medicin, Huddinge, Karolinska Institutet, 2024-2027

Examina och utbildning

Medicine Doktorsexamen, Institutionen för medicin, Huddinge, Karolinska Institutet, 2024
Läkarexamen, Karolinska Institutet, 2010

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI